News & Media | Connect Biopharma - V2.0

top of page

Media Coverage

Healio

Screenshot 2025-10-30 070231.jpg

04/02/26

Rademikibart delivers ‘rapid, deep, durable’ eczema control

Practical Dermatology

Practical Derm.png

04/02/26

Rademikibart Shows High Long-Term Efficacy in Atopic Dermatitis

Medpage Today

04/02/26

'Incredible' Response Rates in Atopic Dermatitis With Drugs From China

The Dermatology Digest

Derm Digest.png

AD Pipeline Watch: Rademikibart Shows Strong Maintenance of Response

HCP Live

HCP Live.jpg

RADIANT-AD: Rademikibart Effective Over 52 Weeks in Atopic Dermatitis, With Cheng Zhou, MD

BioWorld

Simcere’s rademikibart meets phase III endpoints in atopic dermatitis

Fierce Biotech

Fierce Biotech.png

Connect’s Dupixent challenger hits the mark in phase 3 eczema trial

Respiratory Therapy

Respiratory Therapy.png

Rademikibart Tied to Rapid Lung Function Improvement in Asthma, COPD

The BioHub Podcast

Biohub Podcast.png

Episode 130 - Barry Quart - CEO Connect Biopharma

XTalks Clinical Edge

Xtalks Clinical Edge.png

Designing Clinical Trials to Address Asthma and COPD Flare-Ups

NPR BioTech Nation

Biotech Nation.png

A Fast-Acting Dupixent? Dr. Barry Quart, CEO, Connect Biopharma

Dermatology Times

Derm Times.png

Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications

Healio Allergy/Asthma

Screenshot 2025-10-30 070231.jpg

Patients with high FeNO, eosinophil counts have greatest improvements with rademikibart

Bleav in Bengals

Screenshot 2025-10-30 112503.jpg

Bengals have to start FAST with Ickey Woods. Interview with Ickey Woods and Barry Quart (start time: 00:24:00)

WKRC-TV (CBS, Cincinnati)

Screenshot 2025-10-30 111839.jpg

Ickey Woods Foundation 2nd Annual Ickey's Bowling Shuffle Interview

MM+M

Screenshot 2025-10-30 105841.jpg

Ickey Woods and Connect Biopharma team up to tackle acute asthma attacks

Pharmaceutical Executive

Screenshot 2025-10-30 103355.jpg

Connect Biopharma Partners with NFL Legend Ickey Woods and the Javonte Woods Foundation to Improve Asthma Education

Fierce Pharma

Screenshot 2025-10-30 105132.jpg

Connect Biopharma joins NFL star Ickey Woods for asthma education blitz

Business of Biotech Podcast

Screenshot 2025-10-30 104758.jpg

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

The Bio Report

Screenshot 2025-10-30 104255.jpg

A Biologic Designed to Treat Acute Exacerbations of Asthma and COPD

Patient Care

Screenshot 2025-10-30 103832.jpg

Rademikibart Demonstrates Improved Lung Function, Reduced Exacerbations in People with Eosinophilic-Driven Type 2 Asthma

Pharmaceutical Executive

Screenshot 2025-10-30 103355.jpg

Transforming Care for COPD: Q&A with Barry Quart

The Empowered Patient Podcast

Screenshot 2025-10-30 071406.jpg

Next Generation Monoclonal Antibodies for Inflammatory Respiratory Diseases with Barry Quart Connect Biopharma

CityBiz

Screenshot 2025-10-30 071036.jpg

05/21/2025

Q&A with Barry Quart, CEO at Connect Biopharma

Healio Allergy/Asthma

Screenshot 2025-10-30 070231.jpg

Lung function improves for patients with asthma within 24 hours with rademikibart

Pharma Now

Screenshot 2025-10-30 065725.jpg

Connect Biopharma Initiates Phase 2 Seabreeze STAT Study To Test Rademikibart For Treating Acute COPD Exacerbations

Pharma Now

Screenshot 2025-10-30 065725.jpg

05/14/2025

Connect Biopharma Announces New Phase 2 Study To Test Rademikibart For Acute Asthma Exacerbations

Clinical Trials Arena

Screenshot 2025-10-30 065422.jpg

Connect Biopharma begins Phase II trial of drug for acute exacerbations in asthma

Allergy & Respiratory Republic

Screenshot 2025-10-29 151655.jpg

Rademikibart promise for uncontrolled asthma

HCP Live

HCP Live.jpg

04/02/2025

Rademikibart Yields Rapid Improvements in Moderate to Severe Uncontrolled Asthma

San Diego Business Journal

Connect Bio Eyeing Commercial Partner for Inflammatory Disease Treatment

bottom of page